"Patients with rheumatoid arthritis differ by age, duration of illness, accompanying disease, self-injection capability, risk factor for complications, and economic status. Therefore, drug selection considering an individual's condition is crucial."

Rheumatoid arthritis is caused by abnormally activated immune cells attacking joints, thereby inducing inflammation and pain. If not treated early, repeated inflammation over time could result in joint deformities and loss of function.

Along with improved disease awareness, physicians are provided with more treatment options that they can use. For example, Janus Kinase (JAK) inhibitors brought a paradigm shift to rheumatoid arthritis trea